Adaptive graph-based multiple testing procedures

被引:14
作者
Klinglmueller, Florian [1 ]
Posch, Martin [1 ]
Koenig, Franz [1 ]
机构
[1] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
multiple comparisons; treatment selection; multiple endpoints; partial conditional error rate; adaptive design; graphical approach; END-POINTS; CLINICAL-TRIALS; FIXED SEQUENCE; DESIGNS; BONFERRONI; SELECTION; SEAMLESS; STRATEGIES;
D O I
10.1002/pst.1640
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multiple testing procedures defined by directed, weighted graphs have recently been proposed as an intuitive visual tool for constructing multiple testing strategies that reflect the often complex contextual relations between hypotheses in clinical trials. Many well-known sequentially rejective tests, such as (parallel) gatekeeping tests or hierarchical testing procedures are special cases of the graph based tests. We generalize these graph-based multiple testing procedures to adaptive trial designs with an interim analysis. These designs permit mid-trial design modifications based on unblinded interim data as well as external information, while providing strong family wise error rate control. To maintain the familywise error rate, it is not required to prespecify the adaption rule in detail. Because the adaptive test does not require knowledge of the multivariate distribution of test statistics, it is applicable in a wide range of scenarios including trials with multiple treatment comparisons, endpoints or subgroups, or combinations thereof. Examples of adaptations are dropping of treatment arms, selection of subpopulations, and sample size reassessment. If, in the interim analysis, it is decided to continue the trial as planned, the adaptive test reduces to the originally planned multiple testing procedure. Only if adaptations are actually implemented, an adjusted test needs to be applied. The procedure is illustrated with a case study and its operating characteristics are investigated by simulations. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:345 / 356
页数:12
相关论文
共 61 条
[1]  
[Anonymous], 1998, ICH E9 STAT PRINC CL
[2]  
[Anonymous], 1995, Biometrie in der Chemisch-Pharmazeutischen Industrie
[3]   Application of adaptive designs - a review [J].
Bauer, P. ;
Einfalt, J. .
BIOMETRICAL JOURNAL, 2006, 48 (04) :493-506
[4]  
Bauer P, 1999, STAT MED, V18, P1833, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO
[5]  
2-3
[6]   The reassessment of trial perspectives from interim data - a critical view [J].
Bauer, P ;
Koenig, F .
STATISTICS IN MEDICINE, 2006, 25 (01) :23-36
[7]  
Bauer P, 1998, STAT MED, V17, P2133, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO
[8]  
2-2
[9]   Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements [J].
Boessen, Ruud ;
van der Baan, Frederieke ;
Groenwold, Rolf ;
Egberts, Antoine ;
Klungel, Olaf ;
Grobbee, Diederick ;
Knol, Mirjam ;
Roes, Kit .
PHARMACEUTICAL STATISTICS, 2013, 12 (06) :366-374
[10]   A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials [J].
Bowden, J. ;
Mander, A. .
PHARMACEUTICAL STATISTICS, 2014, 13 (03) :163-172